Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,050.00    -69.00 (-6.17%)
Bid:
1,050.50
Ask:
1,051.50
Spread: 1.00 (0.095%)
Market Cap: £3.37b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Voluntary Agreement With CMA

23 Jun 2021 07:05

RNS Number : 7685C
Persimmon PLC
23 June 2021
Β 

23 June 2021

Β 

Persimmon plc

("Persimmon" or "the Group")

Β 

Agreement Of Voluntary Undertakings With The CMA And Closure Of Leasehold Investigation

Β 

Following constructive discussions with the Competition and Markets Authority ("CMA") Persimmon announces that it has agreed a number of voluntary informal undertakings relating to its historic sale of leasehold houses. This agreement brings to an end Persimmon's involvement in the on-going CMA leasehold investigation.

Β 

Persimmon stopped selling leasehold houses in 2017 (other than in exceptional cases) and also introduced an industry-leading Right to Buy scheme enabling customers with leasehold houses to buy their freehold at a price below market value. The informal voluntary undertakings agreed today largely extend existing schemes Persimmon has in place and have been made without any admission of wrongdoing or liability. Working with the CMA to provide further certainty and reassurance to leasehold customers, Persimmon has voluntarily agreed to the following:

Β 

β€’

An extension of its existing Right to Buy scheme to cap the purchase price of a freehold at Β£2,000. This extended scheme will apply to any house leases sold on or after 1 January 2000 and runs until 31 December 2026;

β€’

Customers who have already acquired their freeholds from Persimmon under the existing Right to Buy scheme, and who still own the freehold, can apply to be reimbursed for the difference between the price paid and Β£2,000;

β€’

An extension of its Reservation Period for home buyers from 35 days to 42 days.

Β 

Dean Finch, Group Chief Executive said: "Persimmon has not historically sold leasehold houses in high volumes and introduced a Right to Buy scheme for leaseholders in 2017. However, we are committed to putting our customers first and have voluntarily agreed to extend this existing support to provide further certainty and reassurance.

Β 

"Building on our existing Right to Buy scheme, this agreement provides a fair deal for all leaseholders of Persimmon built houses, extending the opportunity to purchase their freehold at a price well below market value. Today's agreement further demonstrates Persimmon's determination to operate with integrity as we continue to build a business with a long-term, responsible and sustainable future."

Β 

Persimmon has established a dedicated national Freephone helpline number (0800 915 6722) which leaseholders can call for more information. Alternatively, further information can be found at: www.persimmonhomes.com/leasehold.

Β 

For further information, please contact:

Β 

Persimmon

Anthony Vigor, Group Director of Policy and External Affairs

Tel: +44 (0)7767 425822

Β 

Citigate Dewe Rogerson

Kevin Smith / Jos Bieneman

Tel: +44 (0)20 7638 9571

Β 

Notes to editors

Persimmon has previously announced a number of measures in respect of leasehold homes:

Β 

β€’

The Group stopped selling leasehold houses in 2017, except in very limited circumstances where our development's land is itself leasehold, typically a handful of completions a year.

β€’

In 2017 the Group introduced its Right to Buy scheme to enable leaseholders of Persimmon houses to acquire their leases at a price below market value.

β€’

Since March 2019 the Group has been a signatory to the Leasehold Pledge, a government-backed pledge which commits freeholders, developers, conveyancers and managing agents to taking concrete steps to help leaseholders who are stuck in unfair deals.

Β 

Today's announcement brings to a close the CMA's enforcement action on Persimmon, announced alongside three other volume housebuilders, on 4 September 2020.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
AGRUUAKRAWUNUAR
Date   Source Headline
1st Jun 202610:06 amRNSAdmission to Trading
1st Jun 202610:03 amRNSTotal Voting Rights
29th May 202611:57 amRNSDirector/PDMR Shareholding
11th May 20264:56 pmRNSHolding(s) in Company
1st May 202612:12 pmRNSAdmission to Trading
1st May 202612:06 pmRNSTotal Voting Rights
30th Apr 20262:19 pmRNSResult of AGM
30th Apr 20262:18 pmRNSHolding(s) in Company
30th Apr 20267:00 amRNSAGM Trading Statement
23rd Apr 20269:21 amRNSHolding(s) in Company
1st Apr 20261:45 pmRNSAdmission to Trading
1st Apr 20261:43 pmRNSTotal Voting Rights
30th Mar 20263:06 pmRNSDirector/PDMR Shareholding
24th Mar 20263:20 pmRNSDirector/PDMR Shareholding
23rd Mar 20262:12 pmRNSAnnual Report 2025 and Notice of AGM 2026
10th Mar 20267:00 amRNSFull Year Results
2nd Mar 202611:26 amRNSTotal Voting Rights
18th Feb 20261:33 pmRNSNew Issue of Equity Securities
2nd Feb 202610:00 amRNSTotal Voting Rights
13th Jan 20267:00 amRNS2025 Trading Statement
2nd Jan 202612:52 pmRNSTotal Voting Rights
2nd Jan 202611:09 amRNSHolding(s) in Company
30th Dec 20254:44 pmRNSHolding(s) in Company
30th Dec 20254:44 pmRNSHolding(s) in Company
24th Dec 202512:29 pmRNSHolding(s) in Company
24th Dec 202512:29 pmRNSHolding(s) in Company
22nd Dec 20252:22 pmRNSHolding(s) in Company
22nd Dec 20252:22 pmRNSHolding(s) in Company
1st Dec 20252:58 pmRNSBlock listing Interim Review
1st Dec 202512:39 pmRNSTotal Voting Rights
27th Nov 202511:47 amRNSHolding(s) in Company
13th Nov 20257:00 amRNSQ3 Trading Statement
3rd Nov 202511:43 amRNSTotal Voting Rights
1st Oct 202511:45 amRNSTotal Voting Rights
30th Sep 202512:58 pmRNSDirector/PDMR Shareholding
26th Sep 20255:33 pmRNSHolding(s) in Company
17th Sep 20254:44 pmRNSHolding(s) in Company
9th Sep 202510:14 amRNSDirector/PDMR Shareholding
1st Sep 20252:31 pmRNSTotal Voting Rights
13th Aug 20257:00 amRNSHalf Year Results
1st Aug 202511:36 amRNSTotal Voting Rights
9th Jul 20257:23 amRNSUK CMA proposes closure of its investigation
4th Jul 20251:44 pmRNSHolding(s) in Company
1st Jul 202511:38 amRNSTotal Voting Rights
17th Jun 20253:47 pmRNSHolding(s) in Company
2nd Jun 20253:07 pmRNSBlock listing Interim Review
2nd Jun 202511:39 amRNSTotal Voting Rights
14th May 20257:00 amRNSSale of FibreNest
1st May 20252:20 pmRNSResult of AGM
1st May 20252:02 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.